Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.

Slides:



Advertisements
Similar presentations
Changes in graft function in long term renal transplant recipients – analysis by CKD stage and recipient characteristics U.P.Udayaraj, D.Ansell, R.Steenkamp,
Advertisements

UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
UK Renal Registry 15th Annual Report Figure 8.1. Age and gender of PD patients submitted to audit.
UK Renal Registry 16th Annual Report Figure 5.1. Flow chart showing number of patients included in the various analyses.
Is low-dose Aspirin use associated with a reduced risk of colorectal cancer ? a QResearch primary care database analysis Prof Richard Logan, Dr Yana Vinogradova,
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
Exploring centre variation in RRT provision Dr Clare Castledine UKRR clinical fellow.
Survival comorbidity Mrs Retha Steenkamp Senior Statistician UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
Annual Informatics Meeting Changes to the Renal Registry Dataset Fiona Braddon Clinical Informatics Manager.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
Section G – Special Projects Scottish Renal Registry Report 2008 Published by the Information Services Division (ISD Scotland), Common Services Agency.
Advanced CKD Study Daniel Ford UKRR Annual Audit Meeting June 2009.
Improving the utility of comorbidity records Retha Steenkamp UK Renal Registry.
Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.
UKRR Dataset v4.1 How does it fit with the UKRDC ACTIONS IN YOUR RENAL UNIT TO IMPLEMENT THE NEW DATASET UK RENAL REGISTRY 2015 INFORMATICS MEETING: DATA.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
UK Renal Registry 9 th Annual Report 2006 Fig 11.1 UK transplantation prevalence rate per million population by age and gender on 31/12/2005.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
Registry Report Highlights and Insights in 2007/8 User Group 2008.
Chapter 10 Cancer 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Cancer Working.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
Survival after graft failure Dr Lynsey Webb Registrar UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
UKRR – HES linkage James Fotheringham Sheffield Kidney Institute.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.
UK Renal Registry 14th Annual Report Figure Consort diagram detailing incident RRT patients 2002–2006, HES admissions and ONS records included in.
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Similar Outcomes With Hemodialysis and Peritoneal.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
UK Renal Registry 13th Annual Report
2016 Annual Data Report, Vol 2, ESRD, Ch 6
First-year death rates by modality figure 8
UK Renal Registry 10th Annual Report 2007
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Mortality rates in incident ESRD patients figure 9
Summary of the 2013 ERA-EDTA Registry Annual Report
Fig 7.1 Median URR achieved in each renal unit
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
UK Renal Registry 9th Annual Report 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 19th Annual Report
CHAPTER 5 Paediatric Renal Replacement Therapy
Fig 6.1 Frequency of ischaemic heart disease in incident patients
UK Renal Registry 16th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 15th Annual Report
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 12th Annual Report
UK Renal Registry 16th Annual Report
Dialysis outcomes in Australia & New Zealand
Stock and Flow of Haemodialysis Patients Australia
Presentation transcript:

Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry

1.Why is complete data important? 2.How can data completeness be improved?

Epidemiology Describe patterns of health and disease in populations Identify cause of disease Measure need for health services, their use and effects

Lorry DrivingLung cancer Smoking Exposure Outcome Confounder

Dialysis modality - HD Death Old age Exposure Outcome Confounder

Unadjusted Age and sex Predialysis Cr WL status Townsend Quintile URR Ethnicity PRD Time on RRT Phosphate and risk of death in HD patients

Survival of incident RRT patients adjusted for co-morbidity

Missing Data 2001 HD patients = 4230 ConfounderNo. with missing data Age and Gender0 Time on RRT0 Diagnosis105 Ethnicity576 Biochemistry326 WL status3573

Missing data Problems Fewer patients/centres in study Introduce bias as characteristics of those with missing data unknown Solutions Exclude patients from study Statistical techniques to make a ‘educated guess’ about characteristics (imputation)

Or…………… Improve data quality

Plan Improve: –Timeliness of data return –Data completeness

Do -timeliness To be sent quarterly – 2 months after data collection commences Date of Quarter Data collect n period 1 st dataset received Dataset finalised Q1 Q2 Q3 Q4

Do –Data completeness User friendly Key areas –Incident and prevalent patients –Dialysis and transplant patients –Patient numbers –Demographic factors –Quality of care indices

Patient numbers New patients (All RRT) Prevalent patients – HD, PD, Transplant Deaths

Demographics All RRT – incident and prevalent –Ethnicity –Co-morbidity –Primary diagnosis –Referral data

Quality of care indices Dialysis patients URR Phosphate Haemoglobin PTH Blood pressure Transplant patients Haemoglobin eGFR Blood pressure Phosphate

Study – Data completeness In addition to current completeness report Single side of A4 Pilot to Clinical Directors via CD forum Ready to test in RRT centres –Send to IT manager and Clinical Director

Please……….. Feedback your comments to the UKRR